0001209191-19-060910.txt : 20191217 0001209191-19-060910.hdr.sgml : 20191217 20191217170436 ACCESSION NUMBER: 0001209191-19-060910 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191216 FILED AS OF DATE: 20191217 DATE AS OF CHANGE: 20191217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AZAB MOHAMMAD CENTRAL INDEX KEY: 0001309653 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36687 FILM NUMBER: 191290472 MAIL ADDRESS: STREET 1: C/O SUPERGEN, INC. STREET 2: 4140 DUBLIN BLVD., SUITE 200 CITY: DUBLIN STATE: CA ZIP: 94568 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001582313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980661854 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W BUSINESS PHONE: (604) 484-3300 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-16 0 0001582313 Xenon Pharmaceuticals Inc. XENE 0001309653 AZAB MOHAMMAD 200 - 3650 GILMORE WAY BURNABY A1 BRITISH COLUMBIA, CANADA 1 0 0 0 Common Shares 2019-12-16 4 M 0 3086 3.56 A 60647 D Stock Option (Right to Buy) 3.56 2019-12-16 4 M 0 3086 0.00 D 2019-12-31 Common Shares 3086 0 D The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. The shares subject to the option fully vested on December 31, 2012. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3. /s/ Cassandra Robinson, Attorney-in-fact 2019-12-17